SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Charles River Commits $545 Million to Expand Bioanalysis and Drug Development Services

The Massachusetts-based pharmaceutical research and drug development services provider will invest USD 545 million to expand clinical bioanalysis and drug development services.

CRL
SquawkNews Desk

Related stories

Microsoft Restores Service After Widespread Outage Microsoft said full service to its products was restored as of early Saturday, including processing undelivered emails. M impact | EQUITY | Nov 14, 2026, 09:57 AM UTC Microsoft Restores Services After Hourslong Global Outage Microsoft said services were fully restored after an hourslong global outage. M impact | EQUITY | Nov 14, 2026, 09:12 AM UTC Rs.4K cr Ramayana movie VFX maker parent Prime Focus shares in focus after 14x profit jump in Q2; stock up 61% in a year New Delhi, Nov. 14 -- Prime Focus Ltd, the parent company of visual effects and animation studio DNEG, is likely to remain in focus on Monday after announcing its September-quarter L impact | EQUITY | Nov 14, 2026, 09:04 AM UTC Microsoft Restores Service After Global Outage Microsoft said its disruption to central cloud services is over. M impact | EQUITY | Nov 14, 2026, 09:01 AM UTC US Flights to Resume After Air Traffic Network Failure US flights are set to resume after an air traffic network failure disrupted operations. M impact | EQUITY | Nov 14, 2026, 08:06 AM UTC UniCredit Raises $3.5 Billion M impact | EQUITY | Nov 14, 2026, 08:03 AM UTC